Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma

Glioblastoma (GBM) is the most common malignant tumor of the central nervous system with poor prognosis. Although the field of immunotherapy in glioma is developing rapidly, glioblastoma is still prone to recurrence under strong immune intervention. The major challenges in the process of immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Ma, Yiqi, Wu, Zijun, Xie, Ruoxi, Zeng, Fanxin, Cai, Huawei, Lui, Su, Song, Bin, Chen, Lei, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656432/
https://www.ncbi.nlm.nih.gov/pubmed/34899760
http://dx.doi.org/10.3389/fimmu.2021.790674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656432/
https://www.ncbi.nlm.nih.gov/pubmed/34899760
http://dx.doi.org/10.3389/fimmu.2021.790674

Ejemplares similares